Takeda Pharmaceutical Q4 Adj. EPADS $0.16 Down From $0.24 YoY, Sales $7.02B Down From $7.08B YoY

Benzinga · 05/08 07:07
Takeda Pharmaceutical (NYSE:TAK) reported quarterly earnings of $0.16 per share. This is a 33.33 percent decrease over earnings of $0.24 per share from the same period last year. The company reported $7.02 billion in sales this quarter. This is a 0.93 percent decrease over sales of $7.08 billion the same period last year.